Skip to main content Skip to main navigation menu Skip to site footer

An increase in inflammatory cells related to the increase incidence of colitis and colorectal cancer

  • Agung Ary Wibowo ,
  • Andrian Sitompul ,
  • Alfi Yasmina ,
  • Ika Kustiyah Oktaviyanti ,
  • Ardik Lahdimawan ,
  • Essy Dwi Damayanthi ,


Abstract

Background: Inflammation plays an important role in colorectal cancer formation, where colitis inflammatory cells can trigger the production of free radicals that interact with genes in carcinogenesis. Meanwhile, the colonic mucosal epithelium contains goblet cells that function to prevent inflammation. This study aims to examine the correlation between the number of goblet and inflammatory cells in the colon of patients with colorectal cancer, colitis, and healthy colon and their relationship with the incidence of colorectal cancer and colitis.

Methods: Histopathological samples consisting of 30 healthy colons, 30 colons with colitis, and 31 colons with colorectal cancer were examined to obtain the average cell number in 10 or the entire field of view using a light microscope with 400 magnification. Using the Pearson correlation test and Multivariate Multinomial Logistic Regression, these samples were analyzed with SPSS version 26 for Windows.

Results: Consequently, the results showed a weak but insignificant negative correlation between the number of goblet and inflammatory cells in the colon with colorectal cancer (r2=0.055; p=0.200), colitis (r2 = 0.002, p = 0.833), and healthy colon (r2 = 0.110, p = 0.073). The number of inflammatory cells is significantly associated with the incidence of colorectal cancer (OR=1.326; 95%CI=1.155-1.521; p=0.000) and colitis (OR=1.374; 95%CI=1.192-1.583; p=0.000) compared to normal colon.

Conclusion: An increase in inflammatory cells is significantly associated with the incidence of colorectal cancer and colitis.

Keywords: goblet cells inflammatory cells colorectal cancer

References

  1. Long AG, Lundsmith ET, Hamilton KE. Inflammation and Colorectal Cancer. Curr Colorectal Cancer Rep. 2017;13(4):341-351.
  2. Kaur A, Goggolidou P. Ulcerative colitis: Understanding its cellular pathology could provide insights into novel therapies. J Inflamm (United Kingdom). 2020;17(1):1-8.
  3. Allaire JM, Morampudi V, Crowley SM, Stahl M, Yu H, Bhullar K, et al. Frontline defenders: Goblet cell mediators dictate host-microbe interactions in the intestinal tract during health and disease. Am J Physiol - Gastrointest Liver Physiol. 2018;314(3):G360-G377.
  4. Kim YS, Ho SB. Intestinal goblet cells and mucins in health and disease: Recent insights and progress. Curr Gastroenterol Rep. 2010;12(5):319-330.
  5. Birchenough GMH, Johansson MEV, Gustafsson JK, Bergström JH, Hansson GC. New developments in goblet cell mucus secretion and function. Mucosal Immunol. 2015;8(4):712-719.
  6. Knoop KA, Newberry RD. Goblet cells: multifaceted players in immunity at mucosal surfaces. Mucosal Immunol. 2018;11(6):1551-1557.
  7. Sheng YH, Hasnain SZ, Florin THJ, McGuckin MA. Mucins in inflammatory bowel diseases and colorectal cancer. J Gastroenterol Hepatol. 2012;27(1):28-38.
  8. Yao D, Dong M, Dai C, Wu S. Inflammation and Inflammatory Cytokine Contribute to the Initiation and Development of Ulcerative Colitis and Its Associated Cancer. Inflamm Bowel Dis. 2019;25(10):1595-1602.
  9. Itzkowitz SH, Yio X. Inflammation and cancer - IV. Colorectal cancer in inflammatory bowel disease: The role of inflammation. Am J Physiol - Gastrointest Liver Physiol. 2004;287(1 50-1).
  10. Van der Sluis M, De Koning BAE, De Bruijn ACJM, et al. Muc2-Deficient Mice Spontaneously Develop Colitis, Indicating That MUC2 Is Critical for Colonic Protection. Gastroenterology. 2006;131(1):117-129.
  11. Wibowo AA, Pardjianto B, Sumitro SB, Kania N, Handono K. Decreased expression of MUC2 due to a decrease in the expression of lectins and apoptotic defects in colitis patients. Biochem Biophys Reports. 2019;19:100655.
  12. Grondin JA, Kwon YH, Far PM, Haq S, Khan WI. Mucins in Intestinal Mucosal Defense and Inflammation: Learning From Clinical and Experimental Studies. Front Immunol. 2020;11:2054.
  13. Zhang M, Wu C. The relationship between intestinal goblet cells and the immune response. Biosci Rep. 2020;40(10):1-11.
  14. Alipour M, Zaidi D, Valcheva R, Jovel J, Martínez I, Sergi C, et al. Mucosal barrier depletion and loss of bacterial diversity are primary abnormalities in paediatric ulcerative colitis. J Crohn's Colitis. 2016;10(4):462-471.
  15. Roncucci L, Mora E, Mariani F, Bursi S, Pezzi A, Rossi G, et al. Myeloperoxidase-positive cell infiltration in colorectal carcinogenesis as indicator of colorectal cancer risk. Cancer Epidemiol Biomarkers Prev. 2008;17(9):2291-2297.
  16. Terzić J, Grivennikov S, Karin E, Karin M. Inflammation and Colon Cancer. Gastroenterology. 2010;138(6):2101-2114.
  17. Meira LB, Bugni JM, Green SL, Lee CW, Pang B, Borenshtein D, et al. DNA damage induced by chronic inflammation contributes to colon carcinogenesis in mice. J Clin Invest. 2008;118(7):2516-2525.
  18. Kay J, Thadhani E, Samson L, Engelward B. Inflammation-induced DNA damage, mutations and cancer. DNA Repair (Amst). 2019;83:102673.
  19. Leow CC, Romero MS, Ross S, Polakis P, Gao WQ. Hath1, down-regulated in colon adenocarcinomas, inhibits proliferation and tumorigenesis of colon cancer cells. Cancer Res. 2004;64(17):6050-6057.
  20. Periyakoil P, Clarke MF, Sahoo D. Identification of histological features to predict MUC2 expression in colon cancer tissues. bioRxiv preprint. 2019.
  21. Makkink MK, Schwerbrock NMJ, Mähler M, Boshuizen JA, Renes IB, Cornberg M, et al. Fate of goblet cells in experimental colitis. Dig Dis Sci. 2002;47(10):2286-2297.
  22. Guzmán-Mejía F, Godínez-Victoria M, Vega-Bautista A, Pacheco-Yépez J, Drago-Serrano ME. Intestinal homeostasis under stress siege. Int J Mol Sci. 2021;22(10):1-15.
  23. Handayani AR, Widhiastuti E, Susila NKN, Ekawati NP, Widiana IGR, Kusumadjaj MA, et al. Effects of topical vitamin A on conjunctival goblet cell density after small incision cataract surgery. Bali Medical Journal. 2016;5(3):538-542.
  24. Mello R de O, da Silva CMG, Fonte FP, Silva DL, Pereira JA, Margarido NF, et al. Evaluation of the number of goblet cells in crypts of the colonic mucosa with and without fecal transit. Eval number goblet cells crypts Colon mucosa with without fecal transit. 2012;39(2):139-145.

How to Cite

Wibowo, A. A., Sitompul, A., Alfi Yasmina, Oktaviyanti, I. K., Lahdimawan, A., & Damayanthi, E. D. (2022). An increase in inflammatory cells related to the increase incidence of colitis and colorectal cancer . Bali Medical Journal, 11(1), 499–502. https://doi.org/10.15562/bmj.v11i1.2842
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver
Download Citation
Endnote/Zotero/Mendeley (RIS) BibTeX

HTML
0

Total
28

Share

Search Panel

Agung Ary Wibowo
Google Scholar
Pubmed
BMJ Journal

Andrian Sitompul
Google Scholar
Pubmed
BMJ Journal

Alfi Yasmina
Google Scholar
Pubmed
BMJ Journal

Ika Kustiyah Oktaviyanti
Google Scholar
Pubmed
BMJ Journal

Ardik Lahdimawan
Google Scholar
Pubmed
BMJ Journal

Essy Dwi Damayanthi
Google Scholar
Pubmed
BMJ Journal